Tandem Diabetes Care, Inc.

TNDM

US8753722037

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
39.82 ^USD	+1.71%		-2.02%	+34.62%

Jul. 01	Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) added to Russell 2000 Growth Index	CI
Jul. 01	Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) added to Russell 2000 Dynamic Index	CI

Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) added to Russell 2000 Growth Index

July 30, 2024

Latest news about Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) added to Russell 2000 Growth Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) added to Russell 2000 Dynamic Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell Midcap Value Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell Midcap Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell 1000 Growth Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell 1000 Value Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell 3000E Value Index	Jun. 30	CI
Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell 1000 Dynamic Index	Jun. 30	CI
Tandem Diabetes Care Names Jean-Claude Kyrillos COO	Jun. 20	MT
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024	Jun. 20	CI
Tandem Diabetes Care, Inc. and Dexcom, Inc. Enter into Amended and Restated Development Agreement to Original Development Agreement and Amended and Restated Commercialization Agreement to Original Commercialization Agreement	Jun. 18	CI
Oppenheimer Adjusts Price Target on Tandem Diabetes Care to $58 From $47, Maintains Outperform Rating	Jun. 10	MT
Transcript : Tandem Diabetes Care, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 08:00 AM	Jun. 06
Tandem Diabetes Care Insider Sold Shares Worth $258,400, According to a Recent SEC Filing	Jun. 03	MT
Redburn Atlantic Starts Tandem Diabetes Care With Buy Rating, $60 Price Target	May. 30	MT
Transcript : Tandem Diabetes Care, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 11:20 AM	May. 29
Lake Street Adjusts Price Target on Tandem Diabetes Care to $75 From $60, Maintains Buy Rating	May. 22	MT
Stifel Adjusts Price Target on Tandem Diabetes Care to $55 From $45, Maintains Buy Rating	May. 22	MT
Citi Upgrades Tandem Diabetes Care to Buy, Price Target at $57	May. 22	MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Hims & Hers Health, Tesla to Decline	May. 22	MT
Tandem Diabetes Care, Inc. and Unomedical a/s Enter into Amendment Number 1 to Distributor Agreement	May. 16	CI
Transcript : Tandem Diabetes Care, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM	May. 15
Sector Update: Health Care Stocks Mixed in Afternoon Trading	May. 03	MT
Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set	May. 03	MT
UBS Adjusts Price Target on Tandem Diabetes Care to $40 From $28, Maintains Neutral Rating	May. 03	MT

Chart Tandem Diabetes Care, Inc.

Duration

Period

More charts

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Tandem Diabetes Care, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

39.82 USD

Average target price

49.93 USD

Spread / Average Target

+25.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
TANDEM DIABETES CARE, INC.	+34.62%	2.53B
ABBOTT LABORATORIES	-7.03%	180B
MEDTRONIC PLC	-6.32%	99.21B
BECTON, DICKINSON AND COMPANY	-6.15%	66.25B
DEXCOM, INC.	-10.62%	44.74B
CENCORA, INC.	+8.34%	43.82B
HOYA CORPORATION	+11.40%	41.96B
METTLER-TOLEDO INTERNATIONAL, INC.	+11.64%	28.98B
TERUMO CORPORATION	+17.37%	24.07B
WEST PHARMACEUTICAL SERVICES, INC.	-8.87%	23.5B

Other Medical Equipment, Supplies & Distribution